MEDICENNA THERAPEUTICS
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and commercialization of novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines and first in class Empowered Cytokines (ECs) for the treatment of a broad range of cancers. Its proprietary technology platform supports a unique, multi-methodology treatment paradigm that can precisely deliver potent cell-killing agents for cancer as well as actively alter the immunosuppressive tumor micro-environment without harming healthy cells. The company was founded in 2012 and based in Toronto, Ontario, Canada.
MEDICENNA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Medical Therapeutics Wellness
Founded:
2012-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.medicenna.com
Total Employee:
11+
Status:
Active
Contact:
866-393-4891
Email Addresses:
[email protected]
Total Funding:
55.55 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Repertoire Immune Medicines
Repertoire Immune Medicines is a clinical stage biotechnology company.
Current Employees Featured
Founder
Stock Details
Investors List
Cancer Prevention and Research Institute of Texas
Cancer Prevention and Research Institute of Texas investment in Post-IPO Debt - Medicenna Therapeutics
Official Site Inspections
http://www.medicenna.com Semrush global rank: 3.7 M Semrush visits lastest month: 3.74 K
- Host name: 87.186.102.34.bc.googleusercontent.com
- IP address: 34.102.186.87
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago